When did Jubiliant Life Sciences got USFDA approval for selling its generic drugs in the US market?
Others answers (1)
Jubilant Life Sciences got USFDA approval for selling its generic drugs in the US market on January 5, 2015. Mycophenolate Mofetil is used for treatment of migraine, are generics of Merck's Maxalt tablets. These capsules are manufactured by the company's US army Jubilant Cadista Pharmaceuticals, Inc and Rizatriptan tablets are made at Jubilant Generics Ltd, Jubilant Life Sciences.
- Show More